Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Watkins

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Clinical Pharmacology and Therapeutics|April 19, 2017
Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical TrialsD M Longo, G T Generaux, B A Howell, et al.
Pharmacogenetics|December 12, 2001
In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentrationY S Lin, G F Lockwood, M A Graham, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 1999
Molecular and physical mechanisms of first-pass extractionS D Hall, K E Thummel, P B Watkins, et al.
Clinical and Experimental Immunology|November 25, 2014
Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitisD M Foureau, T L Walling, V Maddukuri, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2007
Blood gene expression signatures predict exposure levelsP R Bushel, A N Heinloth, J Li, et al.
Nature Genetics|March 30, 2001
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expressionP Kuehl, J Zhang, Y Lin, et al.
Pharmacogenetics|October 23, 2001
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variantsJ Zhang, P Kuehl, E D Green, et al.
Pharmacological Reviews|June 1, 2004
PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5E G Schuetz, M V Relling, S Kishi, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Clinical Pharmacology and Therapeutics|April 19, 2017
Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical TrialsD M Longo, G T Generaux, B A Howell, et al.
Pharmacogenetics|December 12, 2001
In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentrationY S Lin, G F Lockwood, M A Graham, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 1999
Molecular and physical mechanisms of first-pass extractionS D Hall, K E Thummel, P B Watkins, et al.
Clinical and Experimental Immunology|November 25, 2014
Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitisD M Foureau, T L Walling, V Maddukuri, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2007
Blood gene expression signatures predict exposure levelsP R Bushel, A N Heinloth, J Li, et al.
Nature Genetics|March 30, 2001
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expressionP Kuehl, J Zhang, Y Lin, et al.
Pharmacogenetics|October 23, 2001
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variantsJ Zhang, P Kuehl, E D Green, et al.
Pharmacological Reviews|June 1, 2004
PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5E G Schuetz, M V Relling, S Kishi, et al.
Pageof 10